Therapeutic potential of umbilical cord blood-derived mesenchymal stem cells in ischemic myocardium

Korean Circulation Journal

Volumn 38, Issue 9, 2008, Pages 446-454

  Kim, Yong Sook ^a,b   Ahn, Youngkeun ^a,b   Hong, Moon Hwa ^a,b   Park, Hye Jeong ^a,b   Kwon, Jin Sook ^a,b   Lee, Hyun Ju ^c   Kim, So Hee ^c   Jang, Soo Jeong ^c   Song, Chang Hun ^c,d   Kim, Kye Hun ^a,b   Hong, Young Joon ^a,b   Kim, Ju Han ^a,b   Park, Hyung Wook ^a,b   Jeong, Myung Ho ^a,b   Cho, Jeong Gwan ^a,b   Park, Jong Chun ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

^c JB Stem Cell Research Center   (South Korea)

^d Chosun University   (South Korea)

Author keywords

Bone marrow; Mesenchymal stem cell; Myocardial infarction; Umbilical cord blood

Indexed keywords

CARDIAC ANKYRIN REPEAT PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CORONARY ARTERY LIGATION; DNA MICROARRAY; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENETIC TRANSFECTION; HEART EJECTION FRACTION; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERAPY EFFECT; UNINDEXED SEQUENCE; WESTERN BLOTTING;

EID: 56049124823     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.9.446     Document Type: Article

References (21)

1. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
2. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
3. Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005;102: 11474-9.
4. Piao H, Youn TJ, Kwon JS, et al. Cellular cardiomyoplsty using bone marrow derived mesenchymal stem cells transplantation in post myocardial infarction heart failure. Korean Circ J 2004;34: 1113-21.
5. Lim SY, Jeong MH, Ahn YK, et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Korean Circ J 2005;35:734-41.
6. Zhang H, Fazel S, Tian H, et al. Increasing donor age adversely impacts beneficial effects of bane marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol 2005; 289:H2089-96.
7. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004;22:625-34.
8. Moon MH, Kim SY, Kim YJ, et al. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem 2006; 17:279-90.
9. Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005;79:528-35.
10. Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-65.
11. Tsai MS, Hwang SM, Chen KD, et al. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007;25: 2511-23.
12. Han XJ, Chae JK, Lee MJ, You KR, Lee BH, Kim DG. Involvement of GADD153 and cardiac ankyrin repeat protein in hypoxia-induced apoptosis of H9c2 cells. J Biol Chem 2005;280: 23122-9.
13. Nakada C, Oka A, Nonaka I, et al. Cardiac ankyrin repeat protein is preferentially induced in atrophic myofibers of congenital myopathy and spinal muscular atrophy. Pathol Int 2003;53:653-8.
14. Shi Y, Reitmaier B, Regenbogen J, et al. CARP a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue. Am J Pathol 2005;166:303-12.
15. Chen CL, Lin JL, Lai LP, Pan CH, Huang SK, Lin CS. Altered expression of FHLI, CARP TSC-22 and P311 provide insights into complex transcriptional regulation in pacing-induced atrial fibrillation. Biochim Biophys Acta 2007;1772:317-29.
16. Qi CM, Ma GS, Liu NF, et al. Identification and differentiation of magnetically labeled mesenchymal stem cells in vivo in swines with myocardial infarction. Int J Cardiol 2007.
17. Numaguchi Y, Sone T, Okumura K, et al. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 2006;114 (1 Suppl):I114-9.
18. Tang YL, Zhao Q, Qin X, et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 2005;80:229-36.
19. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998;142:1257-67.
20. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
21. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-88.